Double Latin square study to determine variability and relative bioavailability of methylprednisolone.
The variability and relative bioavailability of methylprednisolone tablets were evaluated utilizing  a double Latin square crossover design in which each of 20 subjects was given four of five treatments. Three different lots of methylprednisolone tablets exhibited virtually identical absorption, with similar ranges and coefficients of variation of some selected bioavailability parameters indicative of lot-to-lot uniformity in bioavailability. Within-lot and between-lot uniformities in bioavailability also were similar, suggesting that the observed variability in serum methylprednisolone levels was not due to manufacturing process variables. With respect to intra-versus intersubject variability, no differences were found for the absorption rate or terminal half-life. In contrast, between-subject variability associated with extent of absorption was greater than that within subjects. Relative to an aqueous suspension, methylprednisolone tablets were fully bioavailable.
D000328:Adult; D000704:Analysis of Variance; D001682:Biological Availability; D006207:Half-Life; D006801:Humans; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage / Q000378:metabolism*; D013223:Statistics as Topic; D013997:Time Factors
D008775:Methylprednisolone